about
Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalySomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyUnexpectedly high rates of obesity and dysglycemia among villagers in Cameroon.Structure-oriented UHPLC-LTQ Orbitrap-based approach as a dereplication strategy for the identification of isoflavonoids from Amphimas pterocarpoides crude extract.Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study.Four-year trends in adiposity and its association with hypertension in serial groups of young adult university students in urban Cameroon: a time-series study.Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based StudiesPeer support for self-management of diabetes improved outcomes in international settings.Fasting insulin sensitivity indices are not better than routine clinical variables at predicting insulin sensitivity among Black Africans: a clamp study in sub-Saharan Africans.Research capacity. Enabling the genomic revolution in Africa.Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa.Urbanization, physical activity, and metabolic health in sub-Saharan Africa.Risk factors of impaired fasting glucose and type 2 diabetes in Yaoundé, Cameroon: a cross sectional study.Metabolic syndrome for sub-Saharan Africans diabetes with peripheral arterial disease: a case-control studyContribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon.The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients: a randomized pilot study.Patterns and correlates of objectively measured free-living physical activity in adults in rural and urban CameroonAssociation between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population.Impact of a pioneer diabetes camp experience on glycemic control among children and adolescents living with type 1 diabetes in sub-Saharan Africa.Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant.Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population.The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian populationWaist circumference does not predict circulating adiponectin levels in sub-Saharan women.Distribution and patterning of non-communicable disease risk factors in indigenous Mbororo and non-autochthonous populations in Cameroon: cross sectional studyOverweight and obesity in children aged 3-13 years in urban Cameroon: a cross-sectional study of prevalence and association with socio-economic statusCardiovascular complications of diabetes mellitus in sub-Saharan Africa.Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study.Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.Prevalence and determinants of electrocardiographic abnormalities in sub-Saharan African individuals with type 2 diabetes.Free-living physical activity energy expenditure is strongly related to glucose intolerance in Cameroonian adults independently of obesity.The Relationship between Adiposity and Insulin Sensitivity in African Women Living with the Polycystic Ovarian Syndrome: A Clamp Study.Predicting physical activity energy expenditure using accelerometry in adults from sub-Sahara Africa.Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS).Diabetes in sub-Saharan Africa.Cardiovascular diseases and diabetes as economic and developmental challenges in Africa.Obesity and type 2 diabetes in Sub-Sahara Africa.Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach.The effect of free diabetes care on metabolic control and on health-related quality of life among youths with type 1 diabetes in Cameroon.Estrogenic activity of isoflavonoids from the stem bark of the tropical tree Amphimas pterocarpoides, a source of traditional medicines.Perceived risk factors of cardiovascular diseases and diabetes in Cameroon.
P50
Q24188346-0463E6BD-6CD1-4C0E-B98B-BC07D4166610Q24239834-E62ABBA5-EBDE-4195-9D21-74B31733A362Q30384844-2D8FB8D6-343B-4BE5-8447-7E331F3A432FQ33457947-2F21C6D7-AD2F-4760-8C06-DEB91802DF9FQ33576295-D87A800D-5BC0-4F68-BA75-B1DFCE931217Q33721807-A91AB585-286C-4CF8-A729-66A75F9B5101Q33790534-D71D21F1-A236-4841-8D8F-5641784557F3Q34026321-82709B40-6A8F-40AC-961A-654177068D1EQ34033120-34266913-B795-478B-A961-E72E01BE4D9EQ34068017-7BACF4AA-0CE6-4B3B-A2C2-A7BAAF502F5FQ34172425-ED724118-D3D8-4319-A762-69522CE8CAA4Q34507317-65408BF7-8E68-4773-80E5-11891A17E1E1Q35071542-7F07928A-0117-41C0-A2B6-EAFD97B32472Q35101873-6D514839-B213-4D65-9A2D-A1AF093240E0Q35494197-4F334211-5B41-4B11-AC72-4847523DEADBQ35671049-8A7A80AC-7297-4835-9AA6-FC531BC498BEQ35792924-0FE9BF88-B49D-4BA9-8705-03AD856ED303Q35853323-5FEE4013-15B9-4C2C-83CC-5FC123B0A61DQ35899334-A7FF2C47-73CA-4B5C-9152-0D95F2257E8AQ35966424-E97A22C9-4B0D-4B0D-9AFA-163FED4DA0DCQ35967595-BE5AEF21-A840-4270-849E-CD6A5E690CCFQ36033708-C8E119CD-81BA-40BB-B6A5-7F7CD8E34D31Q36176023-8172F182-D2BE-4455-9530-3040C7567440Q36203003-DB4321C1-1FC8-4FC3-9324-EC9F846DCD21Q36271131-1BD33FA6-BE75-43FC-9FCD-4BC8635CC92DQ36332142-28C32C26-C539-4B29-ACB3-9C76EA16DCE5Q36343894-E257A764-4FC5-48A2-9770-D2778901F73CQ36907277-AAD27C85-8EF4-467D-A93D-15D4048F19EDQ37041962-6FD4BCCB-7EC7-4BF0-9389-C38FD7B07647Q37067173-CBC64633-FA97-44E0-B705-389EF0242CE9Q37273713-45196728-431E-4D79-B68F-7B88B20C9C15Q37407541-837A61F0-E88B-48C4-AE70-5C53103F485EQ37598023-6D59406C-3974-48DD-AECB-A30586140357Q37770718-EDE92266-64BD-400C-9056-FDC2A5B6EACCQ38165371-0A7811D3-1769-4F5D-B581-AF46D91A126FQ38209712-C8AC9D14-0563-4B46-BDF7-4C43599EC3F9Q38500160-B202CFD7-2EA1-47DE-9A45-69452B3121FBQ38650402-3D44B372-2F25-460F-B6B2-220AFD09C6DDQ38808981-8835209C-9332-4239-9DD8-6983ABC1CF54Q38884734-0A801395-7C88-4D13-9402-4DCCDC5487BD
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jean Claude Mbanya
@ast
Jean Claude Mbanya
@en
Jean Claude Mbanya
@es
Jean Claude Mbanya
@nl
type
label
Jean Claude Mbanya
@ast
Jean Claude Mbanya
@en
Jean Claude Mbanya
@es
Jean Claude Mbanya
@nl
prefLabel
Jean Claude Mbanya
@ast
Jean Claude Mbanya
@en
Jean Claude Mbanya
@es
Jean Claude Mbanya
@nl
P214
P106
P1153
7003365365
P21
P214
P31
P496
0000-0001-9651-8653
P7859
lccn-no2003015607